Open-label study of a regimen consisting of 1 week of lansoprazole, clarithromycin, and amoxicillin followed by 3 weeks of lansoprazole in healing peptic ulcer and eradicating Helicobacter pylori.

Objective: The aim of the study was to assess the efficacy of a regimen consisting of 1 week of low-dose triple therapy with lansoprazole, amoxicillin, and clarithromycin followed by lansoprazole alone for an additional 3 weeks in the eradication of Helicobacter pylori and the healing of peptic ulce...

Descripción completa

Detalles Bibliográficos
Publicado en:Current Therapeutic Research Vol. 61; no. 7; pp. 406 - 414
Autores principales: Archimandritis A, Avgerinos A, Nakos A, Viazis N, Skandalis N, Tzivras M
Formato: research tables/charts Journal Article
Publicado: Elsevier B.V. 2000 Jul
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106918126&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106918126
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0011393X
        KIH
      jtl: Current Therapeutic Research
      issn: 0011393X
      maglogo: N
    pubinfo:
      dt: 2000 Jul
      vid: 61
      iid: 7
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        106918126
        106918126
        2002045641
        106918126
      ppf: 406
      ppct: 8
      formats:
      tig:
        atl: Open-label study of a regimen consisting of 1 week of lansoprazole, clarithromycin, and amoxicillin followed by 3 weeks of lansoprazole in healing peptic ulcer and eradicating Helicobacter pylori.
      aug:
        au:
          Archimandritis A
          Avgerinos A
          Nakos A
          Viazis N
          Skandalis N
          Tzivras M
        affil: Department of Pathophysiology, School of Medicine, National University of Athens, 75, Mikras Asias str, Athens 11527, Greece (aarchim@cc.uoa.gr)
      sug:
        subj:
          Drug Therapy, Combination
          Helicobacter Infections Drug Therapy
          Helicobacter Pylori
          Peptic Ulcer Drug Therapy
          Adolescence
          Adult
          Aged
          Antibiotics Administration and Dosage
          Antiprotozoal Agents Administration and Dosage
          Antiulcer Agents Administration and Dosage
          Biopsy
          Clinical Research
          Confidence Intervals
          Convenience Sample
          Data Analysis Software
          Descriptive Statistics
          Female
          Greece
          Histological Techniques
          Male
          Middle Age
          Prospective Studies
          Treatment Outcomes Evaluation
          Funding Source
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Objective: The aim of the study was to assess the efficacy of a regimen consisting of 1 week of low-dose triple therapy with lansoprazole, amoxicillin, and clarithromycin followed by lansoprazole alone for an additional 3 weeks in the eradication of Helicobacter pylori and the healing of peptic ulcer.Methods: Patients aged >/=16 years with active peptic ulcer diagnosed by endoscopy and H pylori infection were eligible for this prospective, open-label, 3-center study. A triple-drug regimen was used that consisted of lansoprazole 30 mg once daily, amoxicillin 1 g BID, and clarithromycin 250 mg BID for 7 days. Ulcer healing and H pylori eradication were assessed endoscopically 8 to 9 weeks after the start of treatment. Hpylori was determined to be eradicated if both histologic examination and rapid urease testing (4 biopsy samples, antrum [2] and body [2]) were negative.Results: Fifty-five patients who tested positive for H pylori, 49 with duodenal ulcer (DU) and 6 with gastric ulcer (GU), aged 16 to 78 years, were enrolled in the study. Ten patients were lost to follow-up and 1 withdrew from the study because of side effects; 44 patients were included in the per-protocol analyses. H pylori was eradicated in 34 patients, 62% (95% CI, 0.477-0.746) and 77% (95% CI, 0.662-0.885) in the intent-to-treat and perprotocol analyses, respectively. Ulcers were healed in a total of 38 patients (34 DU, 4 GU), 69% in the intent-to-treat population (95% CI, 0.552-0.809) and 86% in the per-protocol population (95% CI, 0.727-0.948). In patients with DU, the rate of healing was 69% in the intent-to-treat analysis (95% CI, 0.546-0.817) and 89% in the per-protocol analysis (95% CI, 0.752-0.971).Conclusions: One week of therapy with lansoprazole 30 mg once daily, amoxicillin 1 g BID, and clarithromycin 250 mg BID, followed by 3 weeks of treatment with lansoprazole 30 mg once daily, effectively healed peptic ulcer but was only moderately effective in eradicating H pylori.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N